Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 514817

Antihyperglycemic action of creatine compared to glibenclamide in type II diabetic patients


Vučić Lovrenčić, Marijana; Znaor, Arijana; Poljičanin, Tamara; Ročić, Petra; Weber, David; Ročić, Boris
Antihyperglycemic action of creatine compared to glibenclamide in type II diabetic patients // Endocrine Abstracts / Trainer, Peter et al. (ur.).
Bristol: BioScientifica, 2011. str. P668-P668 (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 514817 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Antihyperglycemic action of creatine compared to glibenclamide in type II diabetic patients

Autori
Vučić Lovrenčić, Marijana ; Znaor, Arijana ; Poljičanin, Tamara ; Ročić, Petra ; Weber, David ; Ročić, Boris

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Endocrine Abstracts / Trainer, Peter et al. - Bristol : BioScientifica, 2011, P668-P668

Skup
13th European Congress of Endocrinology

Mjesto i datum
Rotterdam, Nizozemska, 30.04.2011. - 04.05.2011

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
creatine; glibenclamide; diabetes; comparison

Sažetak
Possible involvement of creatine in the regulation of glycaemia in diabetic patients has been implicated. The aim of this study was to investigate the short-term effect of creatine on the glycaemic profile during standard meal in comparison to the oral sulfonylurea hypoglycaemic agent glibenclamide, in type II diabetic patients. In a 14-day simmetrically randomized crossover trial, recently detected type II diabetic patients received either creatine (3 g) or glibenclamide (3.5 mg) for five successive days, followed by two days of washout, and crossover to the opposite treatment. Glucose, insulin, c-peptide, and creatine were measured before, and at 60, 90, 120, 180 and 240 min after a standard meal. Both creatine and glibenclamide decreased glucose concentrations vs. basal glucose [-15, 60, 90, 120, 180, and 240 min ; mmol/l]: 12.6±0.83 vs. 12.2±0.56 vs. 12.1±0.57, 15.3±0.63 vs. 13.5±0.70a vs. 13.0±0.57a, 14.8±0.57 vs. 13.8±0.59a vs. 13.4±0.46a, 14.6±0.61 vs. 12.3±0.49b vs. 12.4±0.61a, 12.8±0.76 vs. 10.0±0.40c vs. 10.3±0.41c, and 11.4±0.67 vs. 8.3±0.40c vs. 8.5±0.36c ; (a p<0.05 ; b p<0.01 ; c p<0.001 vs. basal glucose). Treatment with both creatine and glibenclamide increased insulin and c-peptide concentrations after 120 and 240 min (p<0.05, and p<0.01). Short-term peroral administration of creatine and glibenclamide, at the applied doses, elicits similar glucose lowering action. Relative efficacy of creatine in comparison to glibenclamide remains to be established

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
045-1191348-0139 - Biomolekule guanidinskog tipa u šećernoj bolesti (Vučić Lovrenčić, Marijana, MZOS ) ( CroRIS)

Ustanove:
Klinička bolnica "Merkur",
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac,
Nastavni zavod za javno zdravstvo "Dr. Andrija Štampar"


Citiraj ovu publikaciju:

Vučić Lovrenčić, Marijana; Znaor, Arijana; Poljičanin, Tamara; Ročić, Petra; Weber, David; Ročić, Boris
Antihyperglycemic action of creatine compared to glibenclamide in type II diabetic patients // Endocrine Abstracts / Trainer, Peter et al. (ur.).
Bristol: BioScientifica, 2011. str. P668-P668 (poster, međunarodna recenzija, sažetak, znanstveni)
Vučić Lovrenčić, M., Znaor, A., Poljičanin, T., Ročić, P., Weber, D. & Ročić, B. (2011) Antihyperglycemic action of creatine compared to glibenclamide in type II diabetic patients. U: Trainer, P. (ur.)Endocrine Abstracts.
@article{article, author = {Vu\v{c}i\'{c} Lovren\v{c}i\'{c}, Marijana and Znaor, Arijana and Polji\v{c}anin, Tamara and Ro\v{c}i\'{c}, Petra and Weber, David and Ro\v{c}i\'{c}, Boris}, editor = {Trainer, P.}, year = {2011}, pages = {P668-P668}, keywords = {creatine, glibenclamide, diabetes, comparison}, title = {Antihyperglycemic action of creatine compared to glibenclamide in type II diabetic patients}, keyword = {creatine, glibenclamide, diabetes, comparison}, publisher = {BioScientifica}, publisherplace = {Rotterdam, Nizozemska} }
@article{article, author = {Vu\v{c}i\'{c} Lovren\v{c}i\'{c}, Marijana and Znaor, Arijana and Polji\v{c}anin, Tamara and Ro\v{c}i\'{c}, Petra and Weber, David and Ro\v{c}i\'{c}, Boris}, editor = {Trainer, P.}, year = {2011}, pages = {P668-P668}, keywords = {creatine, glibenclamide, diabetes, comparison}, title = {Antihyperglycemic action of creatine compared to glibenclamide in type II diabetic patients}, keyword = {creatine, glibenclamide, diabetes, comparison}, publisher = {BioScientifica}, publisherplace = {Rotterdam, Nizozemska} }




Contrast
Increase Font
Decrease Font
Dyslexic Font